Alnylam Pharmaceuticals Inc.
ALNY | NASDAQ
$244.32
+$4.76 (+1.99%)
At close: Sep 21, 2026, 4:00 PM ET
$244.35
+$0.03 (+0.01%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 1.66B | 966.43M | 812.69M | 866.39M | 819.98M | 496.58M |
Short-Term Investments | 1.25B | 1.73B | 1.63B | 1.33B | 1.62B | 1.38B |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 81.63M | 133.9M | 111.29M | 115.48M | 101.1M | 85.77M |
Receivables | 777.57M | 405.31M | 327.79M | 237.96M | 198.57M | 602.41M |
Inventory | 82.72M | 78.51M | 89.15M | 128.96M | 86.36M | 75.2M |
Other Current Assets | 281.89M | 116.96M | 126.38M | 132.92M | n/a | n/a |
Total Current Assets | 4.05B | 3.3B | 2.98B | 2.69B | 2.81B | 2.61B |
Property-Plant & Equipment | 708.06M | 693.93M | 725.79M | 738.63M | 733.63M | 706.51M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 915.67M | 944.7M | 847.18M | 854.11M | 834.73M | 792.28M |
Total Assets | 4.97B | 4.24B | 3.83B | 3.55B | 3.64B | 3.41B |
Account Payables | 115.72M | 88.42M | 55.52M | 98.09M | 73.43M | 51.97M |
Deferred Revenue | 4.85M | 55.48M | 102.75M | 42.11M | 149.48M | 127.21M |
Short-Term Debt | n/a | 113.02M | n/a | n/a | n/a | n/a |
Other Current Liabilities | 477.27M | 214.4M | 177.16M | 170.98M | 130.66M | 110.75M |
Total Current Liabilities | 1.47B | 1.19B | 967.79M | 767.92M | 695.71M | 585.27M |
Long-Term Debt | 1.01B | 2.36B | 1.02B | 1.02B | 675.7M | 191.28M |
Other Long-Term Liabilities | 1.48B | 398.11M | 1.63B | 1.46B | 1.25B | 1.1B |
Total Long-Term Liabilities | 2.71B | 2.99B | 3.08B | 2.94B | 2.36B | 1.81B |
Total Liabilities | 4.18B | 4.17B | 4.05B | 3.7B | 3.06B | 2.39B |
Total Debt | 1.28B | 2.74B | 1.31B | 1.32B | 997.59M | 521.19M |
Book Value | 789.18M | 67.09M | -220.64M | -158.22M | 588.2M | 1.02B |
Book Value Per Share | 5.86 | 0.53 | -1.77 | -1.30 | 4.97 | 8.84 |
Common Stock | 1.32M | 1.29M | 1.26M | 1.24M | 1.2M | 1.16M |
Retained Earnings | -6.7B | -7.29B | -7.01B | -6.57B | -5.44B | -4.59B |
Comprehensive Income | -20.1M | -34.52M | -23.38M | -44.65M | -33.26M | -43.62M |
Shareholders Equity | 789.18M | 67.09M | -220.64M | -158.22M | 588.2M | 1.02B |
Total Investments | 1.25B | 1.73B | 1.63B | 1.33B | 1.62B | 1.38B |
Add to Watchlist
Select watchlists to add or remove ALNY